36,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

People with diabetes are at higher risk for macrovascular and microvascular complications, and smoking has been shown to exacerbate their diabetes outcomes and accelerate the incidence of secondary symptoms. In the UK, 17% of individuals with Type 1 Diabetes smoke and they continue to do so irrespective of their awareness of the harmful effects of tobacco on their health. The objectives of this work was to examine the experiences, beliefs and attitudes of smokers with Type 1 Diabetes towards smoking, as well as explore their perceptions of existing tobacco control services. The studied…mehr

Produktbeschreibung
People with diabetes are at higher risk for macrovascular and microvascular complications, and smoking has been shown to exacerbate their diabetes outcomes and accelerate the incidence of secondary symptoms. In the UK, 17% of individuals with Type 1 Diabetes smoke and they continue to do so irrespective of their awareness of the harmful effects of tobacco on their health. The objectives of this work was to examine the experiences, beliefs and attitudes of smokers with Type 1 Diabetes towards smoking, as well as explore their perceptions of existing tobacco control services. The studied population identified a number of barriers to quitting and suggested that more tailored education and support from healthcare providers could increase their quitting attempts. Moreover, current nicotine replacement therapy and pharmacological interventions are ineffective in tackling the physical and psychological addictions linked with tobacco. Hence, more rigorous strategies are needed to suppress the cravings associated with smoking.
Autorenporträt
La Dra. Haya Abu Ghazaleh es licenciada y doctora en Farmacología y tiene una maestría en Investigación Clínica. Sus intereses de investigación incluyen los patrones de adicción a la comida en Oriente Medio y el comportamiento de los fumadores en personas con enfermedades crónicas. En la actualidad es profesora del King's College de Londres (Reino Unido) y sigue apoyando la investigación en el grupo de diabetes.